Russia taps nanotech for drug production

Rusnano, the Russia Corporation of Nanotechnologies, is working to develop nanodrugs for cancer treatment. Its goal: Production facilities by 2014 for cancer-fighters with systems of targeted delivery--liposomes, immunoliposomes, and monoclonal antibodies. Release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.